Steve Wagner

553 total citations
8 papers, 341 citations indexed

About

Steve Wagner is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Steve Wagner has authored 8 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in Steve Wagner's work include Cancer Mechanisms and Therapy (2 papers), Ubiquitin and proteasome pathways (2 papers) and Advanced Breast Cancer Therapies (1 paper). Steve Wagner is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Ubiquitin and proteasome pathways (2 papers) and Advanced Breast Cancer Therapies (1 paper). Steve Wagner collaborates with scholars based in Germany, United Kingdom and United States. Steve Wagner's co-authors include Martin R. Sprick, Andreas Trumpp, Steven R. Whittaker, Glenn S. Cowley, David E. Root, Matthias Schlesner, Christian Conrad, Flora Luo, Levi A. Garraway and Roland Eils and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Steve Wagner

8 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Wagner Germany 6 190 160 77 73 58 8 341
Pauline A. Whitehouse United Kingdom 9 193 1.0× 140 0.9× 50 0.6× 20 0.3× 89 1.5× 12 345
Hisayuki Kobayashi Japan 14 301 1.6× 106 0.7× 81 1.1× 57 0.8× 168 2.9× 20 484
Jon Chesebrough United States 6 204 1.1× 186 1.2× 49 0.6× 72 1.0× 26 0.4× 10 426
Zheng Su China 10 210 1.1× 215 1.3× 91 1.2× 18 0.2× 30 0.5× 25 452
Cécile Blanc‐Fournier France 13 117 0.6× 139 0.9× 96 1.2× 38 0.5× 50 0.9× 26 330
Francesca Bizzaro Italy 9 109 0.6× 145 0.9× 92 1.2× 30 0.4× 26 0.4× 13 286
Salo Ooft Netherlands 4 386 2.0× 201 1.3× 186 2.4× 195 2.7× 83 1.4× 5 605
Maike Sonnenberg Germany 7 202 1.1× 156 1.0× 65 0.8× 57 0.8× 42 0.7× 8 361
Vibha Raghavan Canada 8 228 1.2× 171 1.1× 109 1.4× 75 1.0× 125 2.2× 12 399
Sheau Wen Lok Australia 8 244 1.3× 179 1.1× 144 1.9× 16 0.2× 82 1.4× 25 431

Countries citing papers authored by Steve Wagner

Since Specialization
Citations

This map shows the geographic impact of Steve Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Wagner more than expected).

Fields of papers citing papers by Steve Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Wagner. The network helps show where Steve Wagner may publish in the future.

Co-authorship network of co-authors of Steve Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Wagner. A scholar is included among the top collaborators of Steve Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Wagner. Steve Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wagner, Steve, Alexis de Haven Brandon, Melanie Valenti, et al.. (2018). Abstract LB-094: Suppression of inflammatory gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer. Cancer Research. 78(13_Supplement). LB–94. 1 indexed citations
2.
Jabs, Julia, Franziska Maria Zickgraf, Jeongbin Park, et al.. (2017). Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations. Molecular Systems Biology. 13(11). 156 indexed citations
3.
Whittaker, Steven R., Clare Barlow, Mathew P. Martin, et al.. (2017). Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor. Molecular Oncology. 12(3). 287–304. 31 indexed citations
4.
Whittaker, Steven R., Glenn S. Cowley, Steve Wagner, et al.. (2015). Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors. Molecular Cancer Therapeutics. 14(12). 2700–2711. 55 indexed citations
5.
Wagner, Steve, et al.. (2015). mRNA Profiling Reveals Determinants of Trastuzumab Efficiency in HER2-Positive Breast Cancer. PLoS ONE. 10(2). e0117818–e0117818. 35 indexed citations
6.
Höfner, Thomas, Christian Eisen, Corinna Klein, et al.. (2015). Defined Conditions for the Isolation and Expansion of Basal Prostate Progenitor Cells of Mouse and Human Origin. Stem Cell Reports. 4(3). 503–518. 24 indexed citations
7.
Höfner, Thomas, Stephan Macher‐Goeppinger, Corinna Klein, et al.. (2014). Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy. Urologic Oncology Seminars and Original Investigations. 32(5). 678–686. 36 indexed citations
8.
Noz, Marilyn E., et al.. (2011). Radioactivity of Blood Samples Taken from Thyroidectomized Thyroid Carcinoma Patients After Therapy with 131 I. Thyroid. 21(9). 1009–1012. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026